Cowen & Co. analyst Yaron Werber downgrades Instil Bio (NASDAQ:TIL) from Outperform to Market Perform.
SVB Leerink Maintains Outperform on Bio-Techne, Lowers Price Target to $500
SVB Leerink analyst Puneet Souda maintains Bio-Techne (NASDAQ:TECH) with a Outperform and lowers the price target from $550 to $500.